Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Schizophrenia · Autism-Related Irritability
United States, Argentina, Australia, Canada, France +6 more
Sponsor: Insmed Incorporated
Pulmonary Hypertension · Interstitial Lung Disease
United States, Japan, South Korea, Spain, Taiwan
Sponsor: Bristol-Myers Squibb
Schizophrenia
United States, Colombia, Japan, Romania
Sponsor: Showa Inan General Hospital
Ulcerative Colitis in Histologic Remission
Japan
- Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With AsthmaEnrolling By Invitation
Sponsor: Sanofi
Asthma
United States, Argentina, Brazil, Canada, Chile +9 more
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Australia, Canada, India, Japan +2 more
- P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 RiskActive Not Recruiting
Sponsor: PharmaEssentia
Primary Myelofibrosis · Myeloproliferative Neoplasm
United States, Canada, China, Hong Kong, Japan +4 more
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling By Invitation
Sponsor: Sanofi
Wheezing · Asthma
United States, Argentina, Brazil, Canada, Czechia +11 more
Sponsor: Sanofi
Asthma
United States, Canada, Japan
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
United States, Argentina, Austria, Belgium, Bulgaria +14 more
- Japanese Strabismus Outcomes Assessment and Research Group StudyNot Yet Recruiting
Sponsor: Kyoto University, Graduate School of Medicine
Strabismus
Japan
Sponsor: Merck Sharp & Dohme LLC
Metastatic Castration-resistant Prostate Cancer (mCRPC) · Prostatic Neoplasms
United States, Australia, Brazil, Canada, Chile +34 more
Sponsor: Novo Nordisk A/S
Type 2 Diabetes (T2D)
United States, Bulgaria, Croatia, Germany, Greece +6 more
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +15 more
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruiting
Sponsor: AstraZeneca
B-cell Non-Hodgkin Lymphoma · Follicular Lymphoma (FL) · Large B-Cell Lymphoma (LBCL)
United States, Australia, Brazil, Canada, China +11 more
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataRecruiting
Sponsor: Pfizer
Alopecia Areata
United States, Canada, China, Czechia, Japan +6 more
- A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A and B With and Without Inhibitors
United States, Algeria, Bosnia and Herzegovina, Bulgaria, Canada +19 more
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruiting
Sponsor: AstraZeneca
Hyperkalaemia
United States, Brazil, Canada, China, Germany +8 more
- Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid TumorsRecruiting
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Advanced Solid Tumors
United States, Australia, Canada, China
Sponsor: AstraZeneca
Endometrial Cancer · Gastric Cancer · Metastatic Castration-resistant Prostate Cancer · Ovarian Cancer
United States, Canada, China, France, Germany +9 more
- ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsActive Not Recruiting
Sponsor: OncoC4, Inc.
Non Small Cell Lung Cancer
United States, Australia, Belgium, Canada, China +7 more
- First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursRecruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, China, Hong Kong, Japan, South Korea +2 more
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A Without Inhibitors · Haemophilia B Without Inhibitors
United States, Algeria, Australia, Bosnia and Herzegovina, Bulgaria +28 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
- Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)Active Not Recruiting
Sponsor: EMD Serono Research & Development Institute, Inc.
Metastatic or Locally Advanced Unresectable Solid Tumors
United States, China, Japan, Spain, United Kingdom